- Home
- FAMI vs PPBT Comparison
FAMI vs PPBT Comparison
Compare FAMI & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FAMI
- PPBT
- Stock Information
- Founded
- FAMI 2015
- PPBT 2010
- Country
- FAMI China
- PPBT Israel
- Employees
- FAMI N/A
- PPBT N/A
- Industry
- FAMI Packaged Foods
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- FAMI Consumer Staples
- PPBT Health Care
- Exchange
- FAMI Nasdaq
- PPBT Nasdaq
- Market Cap
- FAMI 2.1M
- PPBT 2.1M
- IPO Year
- FAMI 2018
- PPBT N/A
- Fundamental
- Price
- FAMI $1.86
- PPBT $0.57
- Analyst Decision
- FAMI
- PPBT Strong Buy
- Analyst Count
- FAMI 0
- PPBT 1
- Target Price
- FAMI N/A
- PPBT $33.00
- AVG Volume (30 Days)
- FAMI 14.3K
- PPBT 2.8M
- Earning Date
- FAMI 01-26-2026
- PPBT 08-06-2025
- Dividend Yield
- FAMI N/A
- PPBT N/A
- EPS Growth
- FAMI N/A
- PPBT N/A
- EPS
- FAMI N/A
- PPBT N/A
- Revenue
- FAMI $43,831,754.00
- PPBT N/A
- Revenue This Year
- FAMI N/A
- PPBT N/A
- Revenue Next Year
- FAMI N/A
- PPBT N/A
- P/E Ratio
- FAMI N/A
- PPBT N/A
- Revenue Growth
- FAMI N/A
- PPBT N/A
- 52 Week Low
- FAMI $1.43
- PPBT $0.53
- 52 Week High
- FAMI $7.07
- PPBT $13.95
- Technical
- Relative Strength Index (RSI)
- FAMI 57.65
- PPBT 11.95
- Support Level
- FAMI $1.72
- PPBT $0.53
- Resistance Level
- FAMI $1.95
- PPBT $2.36
- Average True Range (ATR)
- FAMI 0.10
- PPBT 0.16
- MACD
- FAMI 0.02
- PPBT -0.13
- Stochastic Oscillator
- FAMI 75.68
- PPBT 2.05
About FAMI Farmmi Inc.
Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.